Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.81%38.44M | 21.17%34.87M | 21.11%31.22M | 13.85%112.43M | 8.68%28.94M | 28.94M | 28.78M | 25.77M | -15.98%98.75M | -9.79%26.62M |
| Cost of revenue | 32.34%27.66M | 17.60%25.37M | 14.87%21.53M | 9.40%80.86M | -2.10%19.64M | 20.9M | 21.57M | 18.74M | -14.40%73.91M | -4.36%20.06M |
| Gross profit | 34.02%10.78M | 31.87%9.5M | 37.74%9.69M | 27.10%31.57M | 41.65%9.3M | 8.04M | 7.2M | 7.03M | -20.36%24.84M | -23.15%6.56M |
| Operating expense | -29.28%3M | 53.15%3.38M | 29.26%2.39M | 86.74%14.34M | -15.91%1.95M | 4.24M | 2.21M | 1.85M | 7.71%7.68M | 17.95%2.32M |
| Selling and administrative expenses | -29.28%3M | 53.15%3.38M | 29.26%2.39M | 86.74%14.34M | -15.91%1.95M | --4.24M | --2.21M | --1.85M | 7.71%7.68M | 17.95%2.32M |
| -Selling and marketing expense | 106.00%103K | 2.67%77K | -21.82%86K | 41.02%335.63K | -10.71%100K | --50K | --75K | --110K | 104.29%238K | 181.86%112K |
| -General and administrative expense | -30.89%2.9M | 54.92%3.31M | 32.49%2.3M | 88.20%14.01M | -16.17%1.85M | --4.19M | --2.13M | --1.74M | 6.10%7.44M | 14.57%2.21M |
| Operating profit | 104.71%7.78M | 22.46%6.12M | 40.77%7.3M | 0.40%17.23M | 73.13%7.34M | 3.8M | 5M | 5.18M | -28.68%17.16M | -35.45%4.24M |
| Net non-operating interest income (expenses) | -79.31%-52K | -60.53%-61K | -47.92%-71K | 26.80%-195.44K | -40.35%-80K | -29K | -38K | -48K | 30.76%-267K | 31.11%-57K |
| Non-operating interest expense | 79.31%52K | 60.53%61K | 47.92%71K | -26.80%195.44K | 40.35%80K | --29K | --38K | --48K | -30.76%267K | -31.11%57K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.09M | -295.83%-132K | -295.83%-132K |
| Less:Other special charges | ---- | ---- | ---- | --4.09M | ---- | ---- | ---- | --4.09M | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 295.83%132K | 295.83%132K |
| Other non-operating income (expenses) | -44.36%424K | -35.85%619K | -2.35%873K | 83.75%3.79M | 291.95%1.17M | 762K | 965K | 894K | 5.61%2.06M | 137.24%298K |
| Income before tax | 79.81%8.15M | 12.72%6.68M | 318.07%8.1M | 10.62%20.82M | 93.79%8.43M | 4.53M | 5.92M | 1.94M | -26.74%18.82M | -24.41%4.35M |
| Income tax | 76.69%1.96M | 13.24%1.65M | 40.55%1.99M | 22.75%5.8M | 44.92%1.81M | 1.11M | 1.46M | 1.41M | -9.45%4.72M | -21.45%1.25M |
| Net income | 80.82%6.18M | 12.54%5.02M | 1,066.41%6.11M | 6.56%15.03M | 113.52%6.62M | 3.42M | 4.46M | 524K | -31.15%14.1M | -25.54%3.1M |
| Net income continuous operations | 80.82%6.18M | 12.54%5.02M | 1,066.41%6.11M | 6.56%15.03M | 113.52%6.62M | --3.42M | --4.46M | --524K | -31.15%14.1M | -25.54%3.1M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 80.82%6.18M | 12.54%5.02M | 1,066.41%6.11M | 6.56%15.03M | 113.52%6.62M | 3.42M | 4.46M | 524K | -31.15%14.1M | -25.54%3.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 80.82%6.18M | 12.54%5.02M | 1,066.41%6.11M | 6.56%15.03M | 113.52%6.62M | 3.42M | 4.46M | 524K | -31.15%14.1M | -25.54%3.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 80.00%0.0054 | 12.82%0.0044 | 960.00%0.0053 | -18.45%0.01 | 115.13%0.0058 | 0.003 | 0.0039 | 0.0005 | -31.14%0.0123 | -25.52%0.0027 |
| Diluted earnings per share | 80.00%0.0054 | 12.82%0.0044 | 960.00%0.0053 | -18.45%0.01 | 115.13%0.0058 | 0.003 | 0.0039 | 0.0005 | -31.14%0.0123 | -25.52%0.0027 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.